Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed plus platinum with or without Caelyx in malignant mesothelioma
2007-005398-73Phase 2Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Feb 2008
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, cisplatin, carboplatin, pegylated liposomal doxorubicin in pleural mesothelioma, sponsored by Karolinska University Hospital. Started Feb 2008; status: terminated.
02
Drugs
pemetrexedcisplatincarboplatinpegylated liposomal doxorubicin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2007-005398-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005398-73.